Trial intelligence / Profile preview

Oral vs IV Sedation in Vitreoretinal Surgery

NCT04346095Phase 4Unknown

Sponsor
Rocky Vista University
Start
Jun 2020
Primary completion
Oct 2020
Modality
Small Molecules
01

Overview

A Phase 4 trial of triazolam in macular hole, Intraocular lens opacification, Vitreous hemorrhage (VH), retinal detachment, epiretinal membrane (ERM), sponsored by Rocky Vista University. Status: unknown.

02

Drugs

triazolam
03

Conditions

macular holeIntraocular lens opacificationVitreous hemorrhage (VH)retinal detachmentepiretinal membrane (ERM)

Beyond the preview

Go deeper on NCT04346095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04346095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call